Home / Pharma Healthcare / GLOBAL MONTELUKAST SODIUM MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

GLOBAL MONTELUKAST SODIUM MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

  • Id : RNR-264812
  • Category : Pharma Healthcare
  • Publish Date : Apr-19
  • Publisher : Research-N-Reports
  • Pages : 123
  • Format : PDF
License Type

Description
Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.

Scope of the Report:
The major raw material for montelukast sodium is 7-chloroquinaldine, isophthalaldehyde, etc. On the global market, supply of raw materials is relatively full. Fluctuations in the price of the upstream product will impact on the production cost of montelukast sodium industry.
We tend to believe this industry is an emerging industry, and the consumption increasing degree will show a rapid growth curve. For product prices, the slow downward trend in recent years will maintain in the future as competition intensifies. Besides, prices gap between different brands will go narrowing gradually. Also, there will be fluctuation in gross margin.
The worldwide market for Montelukast Sodium is expected to grow at a CAGR of roughly 12.1% over the next five years, will reach 390 million US$ in 2024, from 190 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Montelukast Sodium in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Morepen Laboratories
- Mylan
- TAPI
- MSN Laboratories
- Ultratech India
- Aurobindo Pharma
- Hetero Labs
- Unimark Remedies
- Jubilant Cadista
- Aamorb Pharmaceuticals
- Sudarshan Groups
- Ortin Laboratories
- Vamsi Labs
- Adley Group
- Medopharm
- Hengyuan Pharmaceutical
- Arromax Pharmaceutical Technology
- Lihe Wuhan New Chemical Materials
- Shanghai Huachu Chemical

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Montelukast Sodium Amorphous
- Montelukast Sodium Crystalline

Market Segment by Applications, can be divided into
- Tablets
- Chewable Tablet
- Oral Solution

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Montelukast Sodium product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Montelukast Sodium, with price, sales, revenue and global market share of Montelukast Sodium in 2017 and 2018.
Chapter 3, the Montelukast Sodium competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Montelukast Sodium breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Montelukast Sodium market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Montelukast Sodium sales channel, distributors, customers, research findings and conclusion, appendix and data source.